Celldex Therapeutics, Inc.CLDXNASDAQ
Loading
Cash Flow PerformanceElevated
Percentile Rank43
Studio
Year-over-Year Change

Free cash flow yield

Latest
-11.83%
↑ 76% vs avg
Percentile
P43
Within normal range
Streak
4 yr
Consecutive declineElevated
Average
-49.28%
Historical baseline
PeriodValueYoY Change
2025-11.83%-20.5%
2024-9.81%-72.8%
2023-5.68%-12.4%
2022-5.05%-34.6%
2021-3.75%+53.6%
2020-8.08%+94.5%
2019-145.73%+40.0%
2018-242.76%-771.3%
2017-27.86%+13.5%
2016-32.22%-